Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. - Wikidata - awgldk - TriplyDB

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q34812618

about

Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis C Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?NAFLD and Chronic Kidney Disease Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging Evaluation of liver fibrosis: "Something old, something new…"A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.Biomarkers in nonalcoholic fatty liver disease Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease.Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.Liver fibrosis markers of nonalcoholic steatohepatitis.Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.Non-invasive diagnosis of advanced fibrosis and cirrhosis.Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Can NASH be diagnosed, graded, and staged noninvasively?Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan Transient elastography as a screening tool for liver fibrosis in a large hemodialysis population Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease.Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease.Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.

P2860

Q24188065-C859D538-987D-4B9B-98D4-937B329E8518 Q26744631-E2B77299-B845-46AB-8F99-D4B91D20BFB2 Q26752759-82D27C92-D4DC-4346-9D73-4C5654E557FF Q26780252-636EB4BD-99EB-4761-8320-C377581604AE Q26800894-6A15A40C-A30A-4E4A-820D-2EBB81FEED20 Q26828855-493FE85C-899B-4ED0-8C7C-75D2226180BD Q26852019-4B0478E2-0BD1-4C82-9796-1722DA487555 Q26997059-519B2BD8-B290-4FD4-8889-3C028630547A Q27006131-4D8E3025-D32B-48C3-9DCF-9C49530B4084 Q28068532-A7208B97-2EB1-403B-9D5B-84346E3EC65B Q28074377-9A6FF5C2-C793-45B9-A67C-05F33F6CD5D6 Q28080541-35218252-B85E-4B2D-AD48-AB8870EE9C04 Q28082686-990B6E40-9C68-45CC-87C3-1BA974A7106B Q28084035-1B426520-9B95-4515-8AAE-E4C216C4C85C Q28488938-09077B01-495B-440E-A198-B79648FFF1EA Q30355082-1D5C8735-4286-4CDB-8485-587C408FC033 Q30362976-F8450C1D-D2BD-4737-B4ED-05B39931546D Q30366572-21C3D2F5-528D-4826-9DA4-F85FF22BA2AB Q30382172-1672A783-6036-46F1-81EC-85A47B4F798D Q30382278-C15A33DF-D405-4F63-B41C-99BF9B1E655E Q30396692-04DDAD07-83CA-462B-B354-3E6843CBE648 Q30397191-085BE13F-D167-4980-A3CC-E0C1213E6A99 Q30401022-039B11D0-0616-4EAA-B25D-B398CDA6740A Q30407625-7DA94ED0-0B42-4431-9FE2-60D542F2D72C Q30414504-DECCD2CD-AB6B-42A0-825C-638371A4C931 Q30418856-0475E2B8-70AF-4510-A61D-395CC0EF0BBF Q30423320-4AE3676C-8A28-4DF2-BC17-19054D3C837B Q30432576-88FC4D81-57C3-462C-8567-F2E192D4DC0F Q30435948-839A66EC-C3FC-4504-984D-B03D0097D859 Q30451362-5DD5C65C-70AB-4D69-9817-7D386B856B04 Q30471258-BC316FB7-A9F0-4CED-990A-59887CF6FC32 Q30478139-F8DDB1A0-83F4-40AA-AC23-6CED3AF378C1 Q33577504-95D4342C-8C22-4B5B-9631-B22AC58F2D6B Q33618565-EEAEB5DB-3A05-47E1-BE2D-2BF48AE417F6 Q33639969-AD846284-26E5-4ADA-87ED-3B3DB479210C Q33756919-C0754441-8A31-4799-A674-07A02C8B75FD Q33826084-76B7553C-73C6-46AB-B5AB-7586AE08C5F9 Q33886948-5FF3A52B-2D58-4576-A0FE-D0394F1F5B70 Q34219651-A1D5C43C-635B-4C8E-B352-70864A744D4A Q34256132-A0FF030F-007C-4CEE-8002-D1982FD94907

P2860

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q34812618

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@ast

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@en

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@nl

type

label

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@ast

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@en

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@nl

prefLabel

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@ast

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@en

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@nl

P1433

Q34812618-21855F03-E285-4B21-88D7-D287236DDCC3

P1476

Q34812618-CEAA15A4-4296-443E-87EF-35BB01DF2D1E

P2093

Q34812618-1EBEC9F0-9029-4FCA-B1D8-FBE0FCAED78B

Q34812618-611240F5-E10D-41F0-90A4-71645AFFBD92

Q34812618-81F75491-51F2-46BF-ADE8-6F1799352F63

Q34812618-C0E5D695-59B7-4BD9-8C63-E53517FD01E7

Q34812618-C5C9F47F-B9A7-4706-AA60-6189A0C0700D

Q34812618-CA0C257F-06A8-4B1F-A2BD-544E5D3FFF35

Q34812618-EA745970-3F1A-4760-B72C-4CBB692C1152

P2860

Q34812618-0B8C0814-605B-4208-B0A8-869C82C17716

Q34812618-17FCD56B-6FD3-4C22-B8FF-9F12CE4C5620

Q34812618-18A5184D-4B90-4970-9EC4-783CC27D83DA

Q34812618-216D449B-8C12-44A7-95EB-D1612C32A5AE

Q34812618-271EBFBC-E38B-4066-A3AA-FA36E4C52199

Q34812618-2E06E9AC-AD28-426D-B359-E897035365E1

Q34812618-3FD1F2ED-439A-4519-B2D3-53FC0E879612

Q34812618-636D2971-D8BA-4E1D-9407-A9E9436984E5

Q34812618-6707A61E-E764-4744-AB2D-7B009476C746

Q34812618-6913925B-9715-4B4A-BD1A-024FB3DA359B

P304

Q34812618-B2BEAD5C-52E3-4BF0-B764-F966D363483E

P31

Q34812618-897F6DF6-D2B7-4B27-AAE5-0E87A7E3723B

P356

Q34812618-81E9CCD5-5A4D-4E88-98CB-EF9FB653283D

P407

Q34812618-E8560582-136F-42C8-B95B-F75B64364087

P433

Q34812618-36A6A844-F1DF-42E4-9549-2A4321E628C4

P478

Q34812618-7C4E05F6-B137-4BB9-9F1F-0C1324471765

P577

Q34812618-8C2E2816-C120-44D5-9A0E-DA73E405FD58

P5875

Q34812618-453C6BB5-5EB4-49EE-A1D8-8E9C8955B6B2

P698

Q34812618-4BB9A73B-3EDB-42EB-B58E-30CFAA97CB50

P921

Q34812618-745A4E42-49A7-4EFA-A7B3-58F74008BADD

P932

Q34812618-8E295E59-A268-4DF6-AC67-356CAD350E8D

P356

J.CGH.2009.05.033

P1433

Clinical Gastroenterology and Hepatology

P1476

Comparison of noninvasive mark ...... alcoholic fatty liver disease.

@en

P2093

Alison Lydecker

http://www.w3.org/2001/XMLSchema#string

Amy G Shah

http://www.w3.org/2001/XMLSchema#string

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Brent N Tetri

http://www.w3.org/2001/XMLSchema#string

Karen Murray

http://www.w3.org/2001/XMLSchema#string

Melissa J Contos

http://www.w3.org/2001/XMLSchema#string

Nash Clinical Research Network

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Liver fibrosis in overweight patients

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers.

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.

Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

P304

1104-1112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2009.05.033

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26289337

http://www.w3.org/2001/XMLSchema#string

P698

19523535

http://www.w3.org/2001/XMLSchema#string

P921

P932

3079239

http://www.w3.org/2001/XMLSchema#string